Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02331238 · ClinicalTrials.gov registry record · NA

Trial of a Middle School Coach Gender Violence Prevention Program

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
973
Enrollment target

NCT02331238: Completed NA study, sponsored by University of Pittsburgh.

NCT02331238 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 973 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (31% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02331238, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
973 participants
Enrollment target

Study Summary

This cluster-randomized school-based study will examine the effectiveness of a program for the primary prevention of perpetration of teen dating violence and sexual violence among middle school male athletes. Engaging men and boys in preventing violence against women and girls is recognized by major global health organizations as a critical public health strategy. "Coaching Boys into Men" is a theory- and evidence based program intended to alter gender norms that foster teen dating violence/sexual violence perpetration, promote bystander intervention, and reduce teen dating violence/sexual violence perpetration. Coaches receive a 60-minute training and biweekly check-in from a violence prevention advocate to administer the intervention to their athletes via 12 mini-lessons conducted weekly throughout a sport season. In a randomized trial of program effectiveness among high school athletes (Centers for Disease Control and Prevention CE001561-01, PI Miller), male athletes receiving the program demonstrated increased positive bystander intervention behaviors and less verbal abuse perpetration compared to controls. This project seeks to test the effectiveness of this program with younger male athletes in grades 6-8.The innovations are three-fold: (1) testing the efficacy of a novel teen dating violence/sexual violence prevention program for middle school male athletes; (2) training athletic coaches in Teen Dating Violence/Sexual Violence prevention thus implementing primary prevention that does not rely on teachers or classroom time; and (3) integrating the goal of changing gender norms with the technique of a bystander intervention approach to reduce teen dating violence/sexual violence prevention. The experimental design involves a 2-armed cluster randomized- controlled trial in 41 middle schools (38 clusters) in Pennsylvania. Schools will be randomly assigned to either intervention or control (standard coaching) condition. Coaches in intervention schools will receive

Primary Outcome

Assessment of past 3 month positive bystander behavior in athletes when witnessing disrespectful and harmful behavior among peers comparing baseline and follow up summary scores. Athletes report if they have witnessed peers' abusive behaviors in the past 3 months and if witnessed, how they responded (whether they intervened to interrupt the behavior)

Interventions

  • BEHAVIORAL "Coaching Boys into Men" program

Trial Details

FieldValue
Enrollment Target 973 participants
Start Date 2015-03
Est. Completion 2018-12
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT02331238 record still lists

NCT02331238 is an interventional study that assigns participants to a tested intervention. The registered 973 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (31% lower).

The record links to 0 conditions, and to 1 intervention - of which "Coaching Boys into Men" program is the first listed.

NCT02331238 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02331238 about?

NCT02331238 is a clinical study titled "Trial of a Middle School Coach Gender Violence Prevention Program". This cluster-randomized school-based study will examine the effectiveness of a program for the primary prevention of perpetration of teen dating violence and sexual violence among middle school male athletes. Engaging men and boys in preventing violence against women and girls is recognized by major...

What is the current status of trial NCT02331238?

This trial is currently completed. It is a NA study. The enrollment target is 973 participants. The study started on 2015-03. Estimated completion is 2018-12.

What interventions are being tested in trial NCT02331238?

The interventions under investigation include: "Coaching Boys into Men" program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02331238?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02331238's enrollment target sits among peer trials

973 123rd of 2000 higher than 1,878 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06948422 · 974 participants · Phase 3

    A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)

  • NCT05600777 · 975 participants · Phase 3

    A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

  • NCT06541704 · 975 participants · Phase 3

    A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  • NCT06820736 · 975 participants · NA

    A Prospective, Randomized Comparison Of Drainage Techniques After One- Or Two-Level Open Posterior Lumbar Decompression Or Decompression And Fusion

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02331238, the US trial registry maintained by the National Library of Medicine. NCT02331238 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.